The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
So‐Young Huh(Kosin University Gospel Hospital), Kwang Ho Lee(Institute of Chemical Technology), Byung‐Jo Kim(Korea University), Su‐Hyun Kim(National Cancer Center), Ho Jin Kim(National Cancer Center), Byoung Joon Kim(Samsung Medical Center), Ju‐Hong Min(Samsung Medical Center), Woojun Kim(National Cancer Center)
Cited by 84
Related Papers
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
|The Lancet|2019|722
Neuromyelitis optica
|Nature Reviews Disease Primers|2020|464
Digitally tunable physicochemical coding of material composition and topography in continuous microfibres
|Nature Materials|2011|458
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284